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Proper spatial localization of EGFR signaling activated by autocrine ligands represents a critical factor in embryonic
development as well as tissue organization and function, and ligand/receptor binding affinity is among the molecular and
cellular properties suggested to play a role in governing this localization. We employ a computational model to predict how
receptor-binding affinity affects local capture of autocrine ligand vis-a-vis escape to distal regions, and provide experimental
test by constructing cell lines expressing EGFR along with either wild-type EGF or a low-affinity mutant, EGFL47M. The
model predicts local capture of a lower affinity autocrine ligand to be less efficient when the ligand production rate is small
relative to receptor appearance rate. Our experimental data confirm this prediction, demonstrating that cells can use
ligand/receptor binding affinity to regulate ligand spatial distribution when autocrine ligand production is limiting for
receptor signaling. © 2002 Elsevier Science (USA)INTRODUCTION
EGFR2 signaling activated by autocrine ligands is cru-
cially involved in many physiological processes, such as
mammary (Li et al., 1992; Panico et al., 1996; Wiesen et al.,
1999), prostate (Kim et al., 1999), and skeletal tissue orga-
nization (Miettinen et al., 1999), wound healing (Piepkorn
et al., 1998), and liver homeostasis (Chung et al., 2000;
Hisaka et al., 1999; Russell et al., 1993). Moreover, the
importance of the spatial distribution of EGFR signaling in
embryonic development has been demonstrated in a variety
of model organisms (Bier, 1998; Horvitz and Sternberg,
1991; Kornfeld, 1997; Schweitzer and Shilo, 1997; Wasser-
man and Freeman, 1997).
As one example, a number of processes in Drosophila
embryogenesis are governed by highly regulated and spa-
1 To whom correspondence should be addressed. Fax: (617) 258-
0204. E-mail: lauffen@mit.edu.
2 Abbreviations used: EGFR, epidermal growth factor receptor;
EGF, epidermal growth factor; DER, Drosophila EGF receptor;
TGF, transforming growth factor alpha; AR, amphiregulin;
DMEM, Dulbecco’s Modified Eagle Medium; mAb, monoclonal
antibody; PBS, phosphate buffered saline; DCS, dialyzed calf serum;
BSA, bovine serum albumin; WT, wild-type.
0012-1606/02 $35.00
© 2002 Elsevier Science (USA)
All rights reserved.tially localized autocrine and paracrine ligands that bind
the Drosophila EGFR, DER (Schweitzer and Shilo, 1997).
DER along with Spitz, a DER ligand processed as a trans-
membrane protein and subsequently cleaved to activate
DER, are ubiquitously expressed in embryo development,
but DER activation via binding of Spitz is modulated for
diverse effects (Bier, 1998; Wasserman and Freeman, 1997).
Processing of the transmembrane Spitz precursor into its
secreted form is mediated by the chaparone Star in conjunc-
tion with the protease Rhomboid (Klambt, 2002). A second
secreted DER ligand, Argos, can further modulate DER
signaling patterns by competitively inhibiting DER activa-
tion (Schweitzer et al., 1995; Jin et al., 2000). Argos appears
to exhibit more distal effects than does Spitz (Freeman,
1997; Gabay et al., 1997); Spitz has been recently demon-
strated to remain highly localized to its point of release
(Bergmann et al., 2002). During patterning of the ventral
ectoderm, Rhomboid is expressed only in midline cells
(Golembo et al., 1996); Spitz accordingly originates in the
midline and activates DER locally (Gabay et al., 1997;
Wasserman and Freeman, 1997). Ectopic expression of se-
creted Spitz or Rhomboid in the ectoderm or mesoderm
results in ventralization of the embryo (Golembo et al.,
1996), and Argos mutant embryos also show an expanded
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region of ventralization (Gabay et al., 1997). The difference
between spatial ranges of Spitz and Argos, leading to proxi-
mal vs distal effects on DER activity, has been hypothesized
to contribute to the formation of pair dorsal appendages
(Wasserman and Freeman, 1998); this hypothesis is supported
by a recent computational modeling analysis (Shvartsman
et al., 2002).
Similar, but more poorly understood, localization-
dependent effects on DER signaling resulting from compe-
tition between activating and inhibitory secreted autocrine
ligands may be occurring in organization of the fly eye
imaginal disk (Gabay et al., 1997; Baonza et al., 2001).
Moreover, spatially restricted autocrine/paracrine signaling
in the Cacnorhabditis elegans lin-3/let-23 system, the
worm EGF/EGFR system homologue, may be crucially
involved in coordinated uterus and vulva development
(Chang et al., 1999). More broadly yet, mouse mammary
gland development is dependent on autocrine EGFR signal-
ing (Schroeder and Lee, 1998), in a manner that appears to
be strongly influenced by the ligand identity among EGF,
TGF, and AR (Luetteke et al., 1999).
These findings motivate investigation of molecular and
cellular properties which determine the spread of autocrine
ligand before receptor capture, especially for the EGFR
system. Previous theoretical work has offered a set of
properties which might do so, including ligand diffusivity,
receptor expression level, ligand/receptor binding affinity,
and ligand/receptor complex endocytic trafficking rate con-
stants (Shvartsman et al., 2001). The same properties have
been similarly indicated by analogous theoretical treatment
of paracrine factors in formation of morphogen gradients for
developmental regulation (Lander et al., 2002). An experi-
mental study of localized autocrine ligand capture for an
EGF-producing cell line in culture has verified the effect of
EGFR expression level, showing that the fraction of ligand
captured proximally by producing cells falls from nearly 1
to nearly 0 as the ratio of ligand release rate to receptor
synthesis rate increases (DeWitt et al., 2001). A proximal
capture fraction near 1 corresponds to pure autocrine sig-
naling, or “local” operation, whereas a proximal capture
fraction near 0 corresponds to mostly paracrine signaling, or
“community” operation (see Fig. 1).
However, the effects of ligand properties such as receptor-
binding affinity on autocrine ligand spatial range have not
yet been examined, to our knowledge. Because multiple
ligands exist in the EGF family for most organisms (Moghal
and Sternberg, 1999; Yarden, 2001) and exhibit diverse
receptor-binding properties (Shoyab et al., 1989; Derynck,
1992; Chung and Coffey, 2000; Iwamoto and Mekada,
2000), this represents an important property to consider for
its potential role in regulating spatial distribution of EGFR
signaling.
Thus, the question we pose here is: can differences in
EGFR-binding affinity lead to corresponding differences in
spatial localization of autocrine EGF ligands? We start from
our recent analysis of the EGFR autocrine system in engi-
neered B82 mouse fibroblasts (DeWitt et al., 2001), measur-
ing the fraction of WT EGF autocrine ligand captured
locally and the associated fraction of occupied EGFR, en-
abling us to validate a computational model describing this
FIG. 1. Illustration of autocrine vs paracrine ligand signaling. Green cells (center) produce ligand and express corresponding receptor; blue
cells (surrounding) do not produce ligand but express receptor. Black receptors are unoccupied by ligand; red receptors are bound by ligand.
(Left) Case of pure autocrine (or, “local”) operation, with essentially all ligand captured by producing cell. (Right) Case of paracrine (or,
“community”) operation, with very little ligand captured by producing cell.
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system. We then employ this model to generate a priori
prediction of how altering ligand/receptor binding affinity
should affect the fraction of occupied EGFR and the fraction
of EGF autocrine ligand captured locally. The model pre-
dicts that a low-affinity autocrine system will be less
efficient at capturing ligand locally, compared with a higher
affinity counterpart, at low but not high ligand production
rates relative to receptor production rates. To test our
predictions, we generate a novel low-affinity EGF mutant
by making a single-amino acid substitution in EGF, Leu 47
to Met, possessing an approximately eightfold lower bind-
ing affinity for the EGFR compared with wild-type EGF;
this mutation is motivated by its critical role in the lower
AR binding affinity (Adam et al., 1995). The experimental
data are in agreement with the model predictions, thus
showing that cells can regulate the spatial range of auto-
crine EGFR loops not only through processes controlling
ligand release and receptor expression but also by those
modulating the binding affinity of the receptor/ligand pair.
MATERIALS AND METHODS
Construction of Mutant EGFL47M Gene
A low-affinity form of human EGF was constructed by using a
trunctated form of the EGF gene, EGF-Ct, described elsewhere
(Wiley et al., 1998). EGF-Ct contains a signal sequence, the mature
ligand sequence, as well as the transmembane and cytoplasmic
domains. The gene is in pBluescript with NotI and BamHI sites
flanking the gene 5 and 3, respectively. Two PCR primers were
constructed to introduce two-point mutations converting the nu-
cleotides corresponding to leucine47 of the mature ligand to encode
for methionine (5-CAG TAC CGA GAT ATG AAG TGG TGG
GAA-3 and 5-TTC CCA CCA CTT CAT ATC TCG GTA
CTG-3). The primers were used in conjunction with T7 and T3
primers, which anneal to sequences flanking the multiple cloning
site of pBluescript, to generate overlapping primary PCR products.
The final PCR product was amplified by using T7 and T3 primers.
The construct was verified by DNA sequencing. The PCR product
containing the mutant EGF gene was then ligated into the pIRES-
puro vector (CLONTECH Laboratories, Inc., Palo Alto, CA) after
digestion with NotI and BamHI. The construct was again verified
by DNA sequencing.
Production and Purification of EGFL47M
Chinese hamster ovary cells, W3 ATCC, were cultured in a
mixture containing 5% HAM’s F12 and MEM- supplemented
with 5% certified fetal calf serum (all from Gibco) and 5% defined
supplemented calf serum (HyClone Laboratories, Inc., Logan, UT)
and 95% SFX-CHO media (HyClone). Cells were transfected with
pIRESpuro-EGFL47M using LipofectAMINE reagent (Gibco). After
transfection, the medium was supplemented with 40 g/ml puro-
mycin to select transfected cells (CLONTECH Laboratories, Inc.).
We isolated CHO cells expressing higher levels of EGFL47M by FAC
sorting using anti-EGF antibody Z-12 (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA) and anti-rabbit IgG antibody conjugated to
Alexa488 (Molecular Probes, Inc., Eugene, OR). The FACS CHO-
EGFL47M cells were grown in suspension in spinner flasks for 7–10
days. The conditioned media was collected, filtered through a
0.2-m nitrocellulose membrane, and then concentrated by using
ultracentifugation devices (Centricon Plus-80, Millipore) with a
5000 nominal molecular weight cut-off. The concentrated retentate
was then frozen at 20°C until antibody affinity chromatography.
Anti-EGF monoclocal antibodies LB and LC were conjugated to
cyanogenbromide-activated sepharose beads and stored in PBS with
0.02% Azide until use. The concentrated retentate was added to
the conjugated beads and rocked overnight at 4°C in slurry. The
slurry was then loaded into a column (0.8 20 cm) and rinsed with
20 bed volumes of running buffer (PBS). The protein was eluted
with an acid strip (100 mM glycine, 100 mM NaCl at pH 2.5) and
collected in fractions containing 5% collection buffer (3.6 M NaCl,
81 mM KCl, 0.3 M phosphate buffer at pH 8.0). The fractions were
concentrated by using ultracentifugation devices (Centriplus, Mil-
lipore) with a 3000 nominal molecular weight cut-off and tested by
ELISA for concentration of EGFL47M.
SDS-PAGE for was used to confirm the size of the mutant
protein. Precast Tris-Tricine gels designed for small proteins were
prepared and run as described in the instructions using Tris-Tricine
running buffer and sample buffer all purchased from Bio-Rad.
Samples of 125I-EGFLtoM and 125I-EGF were loaded into separate wells
alongside polypeptide standards and run at 100 V for 90 min (same
iodination procedure as described for EGF below). The gel was
exposed for 2 h before imaging using a Bio-Rad Molecular Imager.
Autocrine Cells Expressing Mutant EGFL47M
Parental B82L mouse fibroblasts transfected with the human
EGFR were a gift from Gordon Gill. The cells were grown in
DMEM, 10% DCS (10,000 mol wt cutoff), penicillin, streptomycin,
and 1 M methotrexate (Sigma). The cells were transfected with
pIRESpuro-EGFL47M using FuGENE 6 (Roche Molecular Biochemi-
cals, Indianapolis, IN) and selected and grown using 4.0 g/ml
puromycin (CLONTECH Laboratories, Inc.). Clones were isolated
and checked for EGFL47M expression by ELISA. We varied ligand
secretion and thus the production ratio using clones secreting
different amounts of EGFL47M. We also isolated additional popula-
tions using flow cytometry and cells labeled with anti-EGF anti-
body Z-12 (Santa Cruz Biotechnology, Inc.) and anti-rabbit IgG
antibody conjugated to Alexa488 (Molecular Probes, Inc.). In addi-
tion, we varied the production ratio via receptor appearance by FAC
sorting the original population of B82 EGFR paracrine cells for
various receptor expression levels using an anti-EGFR antibody
13A9 (Genentech) in combination with anti-mouse IgG antibody
conjugated to Alexa488 (Molecular Probes, Inc.) before transfection
with pIRESpuro-EGFL47M.
Bulk Medium Conditioning and
Microphysiometer Assays
These two assays have been described elsewhere (DeWitt et al.,
2001). Briefly, for the bulk medium conditioning assay, parallel
wells of cells were plated. On day 3, the medium was changed to
medium without antibiotics and a given concentration of BB-3103.
On day 4, the medium was switched to 1% DCS, a given concen-
tration of BB-3103, and a given concentration of anti-EGFR block-
ing mAb 225. After the cells conditioned their medium for a given
time (8–14 h), the medium was collected, and the concentration of
EGF or EGFL47M was assayed by ELISA. The EGF sandwich ELISA
has been described elsewhere (Will et al., 1995).
Transwells for the microphysiometer were prepared as described
previously. The transwells with autocrine EGFL47M cells were
plated on the Cytosensor, and a baseline rate of extracellular
acidification (ECAR) was established. Once the baseline was estab-
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lished, the cells were challenged with a given concentration of
exogenous EGF. A transwell was subjected to only one challenge
before being discarded. The normalized, maximal change in the
acidification rate (ECAR-Max) was recorded as a function of exog-
enous EGF concentration. Using an improved microphysiometer
model, similar to a model previously described (DeWittt et al.,
2001), we determined the autocrine ligand concentration as a
function of autocrine ligand secretion rate.
Determination of Binding Rate Constants
Recombinant human EGF was obtained from PeproTech and
iodinated with 125I (NEN Life Science Products) using IODOBEADS
(Pierce) according to the manufacturer’s recommendations. Free
iodine was separated from radiolabeled protein by using a column
(0.8  20 cm) packed with Sephadex G-10. The activity and
concentration were determined by using pre-and postcolumn
samples and a phosphotungstic acid precipitation.
On day 1, B82 EGFR cells were plated in 35-mm dishes at a
1:10 dilution. On day 3, the media was changed to Hepes-buffered
DMEM, 1% DCS, 0.5 mg/ml BSA (D/H/B). On day 4, the plates
were washed two times with cold saline (1 mg/ml polyvinyl
pyrrolidone, 130 mM NaCl, 5 mM KCl, 0.5 mM MgCl2–6H20, 1
mM CaCl2–2H2O 20 mM Hepes) and 0.2 mM phenylarsine oxide
(PAO) in saline was added to each plate to inhibit internalization
(Gibson et al., 1989). The plates were then kept on ice for 20 min.
After 20 min, the PAO solution was removed and 37°C D/H/B was
added. The cells were incubated at 37°C with 1 nM 125I-EGF and
with or without 60 ng/ml cold EGFL47M for times ranging from 1 to
7 min in duplicate. After a given time, plates were washed four
times with cold saline, and the counts associated with the surface
were determined by collecting supernant of an acid strip (50 mM
glycine–HCl, 100 mM NaCl, 2 mg/ml polyvinyl pyrrolidone, 2 M
urea, pH 3.0). In parallel, the total number of receptors on the cell
surface was determined by generating an 125I-EGF equilibrium-
binding curve.
The kinetic rate constants for EGFL47M were determined from
plots of the fraction of total receptors occupied by labeled EGF in
time for sample with and without cold EGFL47M; two nonlinear
equations describing receptor/ligand binding (Eqs. 1 and 2); and a
MATLAB function designed to solve nonlinear curve-fitting prob-
lems. Equation 1 describes the time rate of change of the fraction of
labeled surface complexes (125I-EGF bound to EGFR); equation 2
describes the time rate of change of the fraction of unlabelled
surface complexes (EGFL47M bound to EGFR). The assumptions
embedded in these calculations are that the concentration of
endogenous ligand does not change during the time course of the
experiment and that no processes other than receptor/ligand bind-
ing (such as trafficking) are taking place.
dflabeled
dt
 konlabeled  Llabeled  (1  flabeled  funlabeled)
 kofflabeled  flabeled [1]
dfunlabeled
dt
 konunlabeled  Lunlabeled  (1  flabeled  funlabeled)
 koffunlabeled  funlabeled, [2]
where flabeled  Cslabeled/RsT and funlabeled  Csunlabeled/RsT; Cslabeled is
the number of labeled receptor/ligand complexes, Csunlabeled is the
number of unlabeled receptor/ligand complexes, and RsT is the
total number of receptors on the surface.
First, for one set of experiments, the association and dissociate
rate constants of 125I-EGF were calculated from 125I-EGF-only tran-
sient data. Then, the association and dissociation rate constants of
EGFL47M were calculated by using the previously calculated rate
constants for 125I-EGF in conjunction with the 125I-EGF with cold
EGFL47M transient data. Calculations for the association and disso-
ciation rate constants were based on five sets of independent
experiments.
Computational Autocrine Cell Model
We describe here a computational autocrine cell model which
consists of three parts: (1) system of equations describing autocrine
receptor and ligand binding and trafficking, (2) calculation of
fraction receptor occupied, fR occupied, and (3) rate balance to calculate
fraction ligand capture, fLC. First, we solved a system of equations
describing autocrine receptor and ligand binding and trafficking at
steady state to calculate fR occupied. Equations 3 and 4 describe the
time rate of change of the number of endogenous complexes on the
surface and inside the cell, respectively. Equations 5 and 6 describe
the time rate of change of free surface receptors and total internal
receptors, respectively. The parameter values and how these values
are determined are listed and described elsewhere (DeWitt et al.,
2001). An important input for this model is the autocrine ligand
concentration, Lauto, which is known as a function of VLT, from
previous work on the WT EGF/EGFR system (DeWitt et al., 2001)
and is validated in this work for the low-affinity EGFL47M autocrine
system.
dCsauto
dt
 konauto  Rs  Lauto  koffauto  Csauto  keC  Csauto [3]
dRs
dt
 konauto  Rs  Lauto  koffauto  Csauto
 keR  Rs  krec  (1  fR)  RiT  Vs [4]
dCiauto
dt
 keC  Csauto  [krec  (1  fR)  kdgr  fR]  Ciauto [5]
dRiT
dt
 keR  Rs  keC  Csauto
 [krec  (1  fR)  kdgr  fR]  RiT, [6]
where konauto is the association rate constant of the autocrine
ligand, koffauto is the dissociation rate constant of the autocrine
ligand, keC is the internalization rate constant for receptor/ligand
complexes, keR is the constitutive internalization rate constant, krec
is the rate of recycling, kdgr is the rate of degradation, fR is the
fraction of receptors degraded, and Vs is the synthesis rate of
receptors.
Once the above system of equations is solved, fR occupied is calcu-
lated based on occupied surface receptors, on total occupied recep-
tors, and on a combination of surface and internal occupied
receptors. We used Eq. 7 to combine surface occupied receptors
with a fraction “x” of internal receptors to better fit our computa-
tional model to bulk medium experimental results.
fR occupied 
Csauto  x  Ciauto
Csauto  Rs  RiT
[7]
Finally, to determine fLC from fR occupied , we recognize that a
balance must exist between the rate of ligand capture by cell
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receptors and the rate of receptor binding by ligand (Eq. 8). Total
ligand secretion rate, VLT, and receptor appearance rate at the cell
surface, VR, were determined as described previously (DeWitt et al.,
2001).
fLC  VLT  fR occupied  VR [8]
The value of “x” in Eq. 7 was estimated based on the closest
visual match between experimental bulk medium conditioning
results and our model output from Eq. 8, both in terms of fLC, for
the wild-type autocrine system; the best “x” was determined to be
0.6, whereas for the mutant autocrine system, it was determined to
be 0.5. We attribute this difference to the lower receptor-binding
affinity of the mutant ligand, which is expected to yield enhanced
dissocation of the complex during endocytic trafficking (French and
Lauffenburger, 1997).
RESULTS
Computational Model for Autocrine Ligand Capture
Previously, we reported that an important parameter
governing autocrine ligand capture is the ratio of ligand
production to receptor appearance, VLT/VR (DeWitt et al.,
2001). Ligand production is equal to the total ligand secre-
tion rate and is calculated from measurement of the con-
centration of EGF in the bulk medium when nearly all
autocrine ligand appears in the medium (i.e., in the pres-
ence of excess blocking anti-EGFR mAb 225). Receptor
appearance at the surface is due to both synthesis and
recycling and is simply the number of surface receptors
multiplied by the constitutive internalization rate constant
when autocrine ligand production is negligible. We pre-
sented the fraction ligand capture (fLC) and the fraction of
occupied receptors (fR occupied) as a function of this ratio for a
WT EGF/EGFR autocrine system engineered into B82
mouse fibroblasts. Our data were obtained by using two
experimental assays: first, a bulk medium conditioning
assay indirectly measures fLC by measuring ligand escaping
the producing cells; second, a Cytosensor microphysiom-
eter assay measures the degree of receptor activation and, in
combination with a computational microphysiometer
model, permits calculation of fR occupied. The measurements
from these assays have been demonstrated to reflect the
amount of ligand that is self-captured by producing cells
before being lost to bulk medium by diffusion (Lauffen-
burger et al., 1998).
These two quantities are related in that every EGF
molecule captured by the cell results in an occupied EGFR,
i.e., a simple rate balance (see Materials and Methods) can
calculate fLC from fR occupied, with fR occupied determined by using
a computational autocrine cell model (see Materials and
Methods). Two limiting cases exist for fR occupied calculations:
the first considers total cell EGF/EGFR complexes, both
internal and surface, while the second considers only sur-
face complexes. fR occupied based on total complexes is always
higher than fR occupied based on surface complexes because
internal complexes arise from endocytosed surface com-
plexes; occupied surface receptors have approximately a
10-fold enhancement in their internalization rate constant
(keC  0.3 to 0.1 min1) over unoccupied receptors (keR 
0.03 min1). When we use these two extreme values of
fR occupied to calculate fLC, we obtain predictions that should
provide upper and lower limits for fLC.
In Fig. 2, we can see that fLC decreases as the production
ratio increases. fLC calculated with total complexes begins
to decrease from unity at a production ratio of 0.5, while fLC
calculated with surface complexes does not reach unity for
any value of the production ratio. The points in Fig. 2
represent data previously reported for WT EGF capture as
measured by bulk medium conditioning (DeWitt et al.,
2001). The two solutions from our autocrine computational
model for the most part envelop, as they should, the results
obtained from bulk medium conditioning experiments:
model predictions derived from total receptors calculate a
higher fLC for a given VLT/VR, and those derived from
considering only surface receptors calculate a lower fLC
compared with experimental results. This envelopment
breaks down at high values of VLT/VR, where all receptors
are essentially saturated; this happens because the endo-
cytic internalization rate constant is assumed to be un-
changing with occupied receptor number in the model,
whereas in reality, the value of this parameter diminishes
with increasing occupied receptor number (the phenom-
enon termed “saturation of internalization;” see Lauffen-
burger and Linderman, 1993). Because the ligand capture
fraction is basically 0 at this point, however, this loss of
model accuracy is not a significant problem.
FIG. 2. Calculated fraction ligand capture from a computational
model as a function of the production ratio agrees with experimen-
tally measured fraction ligand capture. Using fR occupied results gen-
erated from a computational model and microphysiometer experi-
mental data for the WT EGF/EGFR autocrine system (DeWitt et al.,
2001), we employed a kinetic rate balance (for ligand capture by
receptors equalling receptor binding by ligand) to convert fR occupied to
fLC for the wild-type autocrine system. Calculations were based on
either total occupied receptors (dashed curve), surface occupied
receptors (bold curve), or 100% surface complexes plus 60%
internal complexes (dashed curve). The symbols are from bulk
medium conditioning experimental results for this system (DeWitt
et al., 2001).
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To enable a unified prediction of the experimental data,
we determined the combination of surface and internal
complexes required to yield the measured signal. As shown
by the dashed line model computation in Fig. 2, the com-
bination of 100% of the surface complexes plus 60% of the
internal complexes provides the best quantitative agree-
ment with the experimental data (based on a residual
minimization analysis). This comparison thus completely
specifies all the parameters in our computational autocrine
cell model from the WT EGF system, permitting a priori
prediction of behavior as system parameters such as ligand/
receptor binding affinity are varied.
Predictions for Effect of Binding Affinity
on Autocrine Ligand Capture
Given the complete specification of our computational
autocrine cell model for the WT EGF autocrine system, we
can now generate a priori predictions for the effect of
changing the receptor/ligand binding affinity on fLC as a
function of the ligand-to-receptor production ratio, VLT/VR.
We use the model parameters determined above, changing
only the binding constants. An important piece of the
model computation is the linear relationship of effective
local autocrine ligand concentration, [L]auto, to ligand pro-
duction rate, VLT. We will prove later (see Fig. 5) that this
same linear relationship holds for the low-affinity autocrine
cells as for the WT autocrine cells. Thus, using the WT EGF
system parameters, except with increasing dissociation rate
constant (Fig. 3a) or decreasing association rate constant
(Fig. 3b), the model predicts expected shifts in fLC vs VLT/VR.
For a given binding equilibrium constant, a decrease in the
association rate constant has a larger effect in decreasing a
cell’s capture efficiency than an equivalent increase in the
dissociation rate constant; however, in both cases, for a
decreased binding affinity, cells are predicted to be less
efficient at capturing autocrine ligand. The difference be-
tween the WT and low-affinity curves is predicted to be
significant, however, only for values of the ligand-to-
receptor production rate ratio of 1; i.e., when ligand
production is limiting for receptor binding (DeWitt et al.,
2001).
Low-Affinity EGF Mutant Ligand Properties
To experimentally test the model prediction that a low-
affinity autocrine system is less efficient at capturing ligand
than a higher affinity counterpart under ligand production-
limiting conditions, we constructed a novel, low-affinity
counterpart to our EGF/EGFR autocrine system. Several
possibilities exist to alter the binding affinity of a receptor/
ligand pair; and previous investigations indicated ways to
alter the interaction of EGF for the hEGFR. Previous work
has shown that Leu47 in the C-terminal region of EGF is
important for high-affinity binding to the EGFR. Mutations
of this residue from leucine to any of seven other amino
acids (Ile, His, Pro, Ala, Gly, Asp, Arg) resulted in all
mutations exhibiting a lower affinity to EGFR compared
with wild-type (Matsunami et al., 1991). AR studies also
indicated the importance of residue 47 of EGF. AR binds to
the EGFR with approximately a 10-fold lower affinity than
EGF (Shoyab et al., 1989). The mature form of AR does not
have a leucine residue at the position analogous to position
47 of EGF; rather, AR has a methionine (Met86). Adam et
al. (1995) found that modification of Met86 to Leu86 in a
C-terminally extended AR construct increased the mito-
genic potency nearly 2 orders of magnitude, corresponding
to a possible increase in binding affinity to that of EGF for
the EGFR.
With these investigations in mind, we created a low-
affinity EGF/EGFR autocrine system by introducing a con-
servative mutation into EGF at residue 47; the leucine at
residue 47 in wild-type EGF was converted to methionine.
EGFL47M was then expressed in B82 EGFR cells, creating a
new autocrine cell line. We then produced and purified
FIG. 3. Decreasing the binding affinity of an autocrine receptor/
ligand pair decreases ligand capture efficiency in a manner depen-
dent on whether the association or dissociation rate constant is
altered. Using our computational model, fLC is predicted for EGF as
a function of VLT/VR based on the parameter specification for the
WT EGF/EGFR system shown in Fig. 1, except across a ranges of
values of autocrine ligand dissociation rate constant, koff (A), and
association rate constant, kon (B).
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EGFL47M for characterization using Chinese hamster ovary
(CHO) cells. We used SDS-PAGE to confirm that EGFL47M
has the same electrophoretic mobility as EGF, and thus the
same approximate molecular weight. In addition, by visu-
alizing polypeptide standards run in adjacent wells, both
ligands appeared at the expected molecular weight, 6.2 kDa
(results not shown).
We measured the association and dissociation rate con-
stants of EGFL47M to the EGFR using competitive radiola-
beling experiments. B82 EGFR cells were pretreated with
PAO to inhibit internalization processes, and the rate
constants were then calculated from data taken at 37°C. We
ran two parallel sets of samples; the first set was challenged
with only 125I-EGF, while the second set was challenged
with 125I-EGF and cold EGFL47M. We measured the number of
125I-EGF surface-associated counts in time. As we would
expect, EGFL47M competes with 125I-EGF for binding to the
EGFR; therefore, samples containing cold EGFL47M and 125I-
EGF render low counts than those with only 125I-EGF as
shown in Fig. 4a. Using five data sets, we used a nonlinear
curve fitting function to calculate the association and
dissociation rate constants for 125I-EGF and EGFL47M.
As shown in Fig. 4b, the values calculated for the asso-
ciation rate constants of 125I-EGF and EGFL47M are 0.14 and
0.097 nM1 min1, respectively; dissociation rate constants
are 0.18 and 0.98 min1 respectively. Kinetic rate constants
for 125I-EGF have been previously reported in literature, and
our values for EGF agree well with those reported, kon (nM1
FIG. 4. (a) Fewer labeled complexes are formed at a given time when cold EGFL47M is added to medium containing 125I-EGF. B82 EGFR
cells pretreated with 0.2 mM PAO were incubated with 1 nM 125I-EGF and with (red squares) or without (black squares) 10 nM EGFL47M for
1, 2, 3, 4, 5, 6, and 7 min in duplicate. The number of 125I-EGF molecules associated with the surface was collected and counted. (b) Binding
affinity of EGFL47M is lower than EGF, primarily due to a change in the dissociation rate constant. Using five sets of data from radiolabeling
experiments as presented in Fig. 3a, the association and dissociation rate constants of 125I-EGF and EGFL47M were calculated by using a
nonlinear curve-fitting function.
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min1)  0.063  0.02, koff (min1)  0.16  0.05 for EGF
(French et al., 1995). While the association rate constants
we measured for EGF and EGFL47M are relatively close, the
dissociation rate constants are noticeably different. The
dissociation rate constant of EGFL47M is considerably larger
than that of EGF, leading to approximately an eightfold
decrease in the binding affinity of EGFL47M (KD  10 nM) for
the EGFR compared with wild-type EGF (KD  1.3 nM).
Model Predictions and Experimental Test Using
EGFL47M Autocrine System
As noted earlier, our model predictions require that the
linear relationship between Lauto and VLT discerned from
wild-type EGF microphysiometer data analysis holds for
the low-affinity EGF mutant system. We now validate this
by applying the same analysis to microphysiometer data
collected using low-affinity autocrine cells as we did previ-
ously to our wild-type autocrine system (Appendix B in
DeWitt et al., 2001) to generate Lauto vs VLT for our low-
affinity system. We expect that the relationship between
Lauto and VLT should be the same for both wild-type and
low-affinity systems, that is, the concentration of autocrine
ligand is only a function of the ligand secretion rate. Fig. 5
shows that the slopes of Lauto vs VLT calculated using
wild-type and low-affinity ligand-producing cells are statis-
tically equivalent; the best-fit individual slope values are
0.0036  0.0001 and 0.0045  0.0010, respectively, and the
hypothesis of equivalent slopes was not rejected (P  0.65)
by ANOVA. The mutant ligand-producing cells exhibit
greater variance in their behavior here than do the wild-type
ligand-producing cells, because the latter were clonal with
tet-off system for regulating ligand synthesis, whereas the
former were generated from different clones. Also, the
mutant ligand-producing cells appeared to be limited by
their particular promoter in the ligand synthesis rate they
were capable of generating. This result validates our use of
this relationship to predict the effects of altering binding
affinity on fraction receptors occupied and thus fraction
ligand captured.
To now specifically test our model predictions for the
EGFL47M/EGFR autocrine system, to compare the computa-
tional results with the experimental data on local ligand
capture as a function of the production ratio for these cells
(Fig. 6). The black dashed line and black points correspond-
ing to the wild-type EGF situation are repeated from Fig. 2,
recalling the best-fit obtained with signaling from 60% of
the internalized ligand/receptor complexes. The red points
in Fig. 6 correspond to the mutant EGF situation, with the
two red dashed curves representing the model predictions
for 60 and 50% intracellular complex signaling; for this
ligand, 50% provides a better fit, likely arising from the
enhancement of ligand/receptor complex dissociation dur-
ing endocytosis for the lower-affinity ligand (French and
Lauffenburger, 1997). With this reasonable single-parameter
modulation, the model predictions are borne out by the
data, both showing that the low-affinity EGF mutant is
locally captured less efficiently as long as the ligand-to-
receptor production ratio is less than unity.
Consider, for instance, a ligand/receptor production ratio,
VLT/VR, of 0.3. For wild-type EGF binding affinity, less than
10% of the released ligand escapes proximal capture,
whereas for the roughly eightfold lower EGFL47M binding
affinity, more than 50% escapes local capture. Although
this disparity for our specific EGFL47M case may not seem
major, reference to Fig. 2 makes clear that very large
differences in local capture fraction can occur for greater
changes in affinity.
DISCUSSION
In this work, we have determined how the ability of cells
to locally capture autocrine ligands can be influenced by
receptor-binding affinity. We have accomplished this by
comparing the local capture of wild-type EGF (KD  1.3 nM)
vs an EGFL47M mutant (KD  10 nM) produced as autocrine
factors in EGFR-expressing B82 cells, employing a combi-
nation of ELISA and microphysiometer measurements in
the absence and presence of an anti-EGFR-blocking anti-
body at saturating concentration and for varying levels of
ligand and receptor expression. ELISA measures the fraction
of ligand escaping capture by EGFR binding, while the
microphysiometer measures the fraction of EGFR binding
ligand (Oehrtman et al., 1998; Lauffenburger et al., 1998;
DeWitt et al., 2001); together, these two assays, along with
independent evaluation of the key rate constants for bind-
ing and endocytic trafficking, enable validation of a com-
putational model for autocrine ligand capture dynamics.
The model predicts, and our experimental data for wild-
type EGF confirms, that an important quantity governing
the fraction of locally captured autocrine ligand is the ratio
of the rate of ligand secretion, VLT, to the rate of receptor
appearance on the cell surface (via both new synthesis and
endocytic recycling), VR. As can be seen in Fig. 2, local
capture is near 1 for low values of this ratio and diminishes
to near 0 for high values of this ratio. When the ligand
production rate is too great relative to the rate at which
receptors arrive on the cell plasma membrane, the receptors
quickly become saturated so that most of the additional
ligand diffuses away to more distal locations, as illustrated
in Fig. 1. Basically, the system can transition between
operating in predominantly autocrine mode (the fraction
locally captured near 1) to predominantly paracrine mode
(the fraction locally captured near 0), depending on the
value of VLT/VR.
The central question of our work here, then, is how the
value of ligand/receptor binding affinity, KD, influences
local autocrine factor capture; i.e., whether the system is
operating mainly in autocrine or paracrine mode. The
computational model predicts that for lower affinity ligand,
the fraction locally captured should be diminished—but
only when the ratio VLT/VR is sufficiently small. Our
experimental data for our EGF B82 cell system here, as seen
in Fig. 6, confirm this prediction. Indeed, there exists a
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window of ratios of ligand-to-receptor production rates in
which a reduction in ligand/receptor binding affinity leads
to reduction in local autocrine capture. Another way to
look at this is that the position of the curve of local ligand
capture as a function of VLT/VR varies with the value of KD;
for increasing KD (lower binding affinity), this curve shifts
to the left. In our experimental system here, comparing
wild-type EGF and the EGFL47M mutation, the difference in
KD values is only approximately eightfold, so that the shift
is significant but not large; the change in the value of the
ratio VLT/VR for which 50% of the produced ligand is
captured locally changes by roughly four-fold. The model
predicts that more quantitatively dramatic changes should
be found for greater differences in KD values. One can infer,
accordingly, that for similar ligand production rates, a
high-affinity ligand system may operate in mainly auto-
crine mode, while a low-affinity ligand system may be
operating in mainly paracrine mode.
This work has been motivated by the myriad roles of
autocrine ligand/receptor loops in embryonic development
and tissue organization, especially in regard to the EGFR
system (Freeman, 1996; Newman and Sternberg, 1996; Van
Buskirk and Schupbach, 1999; Freeman, 2000), as well as in
pathological dysregulation (Casci and Freeman, 1999). Be-
cause quantitative changes in molecular and cellular prop-
erties can lead to qualitative alterations in phenotypic
behavior, it is important to pursue quantitative understand-
ing of the effects molecular and cellular parameters on
operation of the EGFR autocrine system. As one example,
in Drosophila oogeensis, DER-mediated pattern formation
by a network of stimulatory and inhibitory autocrine loops
induces the formation of respiratory appendages on the
dorsal side of the eggshell. This patterning can be strongly
governed by the comparative spatial ranges of the secreted
Spitz and Argos DER ligands (Wasserman and Freeman,
1998; Shvartsman et al., 2002). A variety of properties have
been theoretically proposed to influence the distance of
ligand diffusion before capture by cell receptor binding,
including ligand effective diffusivity through the extracel-
lular matrix (potentially affected by ligand/matrix interac-
tions); ligand/receptor binding affinity, and ligand/receptor
endocytic internalization and recycling rates (Chu et al.,
1996; Strigini and Cohen, 1999; Shvartsman et al., 2001;
Teleman et al., 2001; Lander et al., 2002). However, none of
these properties has previously been investigated for its
actual effects on autocrine ligand spatial localization. Our
findings that receptor-binding affinity can, in fact, help
govern the ability of cells to capture autocrine ligand locally
are thus novel. At first look, the reduction in local ligand
capture for a lower-affinity ligand seems straightforward—
but, as can be seen in Fig. 6, this molecular-property effect
turns out to strongly depend on a cellular-property effect:
that of the ligand-vs-receptor appearance rates ratio. This
means that the extent to which receptor binding affinity
regulates autocrine ligand spatial localization may vary
with cell expression levels of both ligand and receptor as
well as other processes, such as endocytic trafficking, that
influence cell receptor levels. Therefore, different investi-
gators may observe diverse results for such a question—or
even a deceivingly simple question such as whether a given
ligand/receptor pair is operating in autocrine mode or
paracrine mode—depending on their system of study and
even confounding protocol conditions for a given system. It
is important to understand the multivariable nature of this
complicated dynamic phenomenon for proper intepretation
of experimental findings, hence our aim of validating pre-
dictions of a computational model in which many key
features of the phenomenon are represented.
Concerning the DER/Spitz/Argos system in particular, it
is not clear whether the literature reports of highly local-
ized Spitz effects in contrast to the more distal Argos
influence (e.g., Stemerdink and Jacobs, 1997; Gabay et al.,
1997; Bergmann et al., 2002) are necessarily due to Argos
possessing lower DER-binding affinity. Experimental stud-
ies of Spitz and Argos binding have given mixed results. Jin
et al. (2000) found that the KD values for Argos and Spitz
binding to DER immobilized on a BIACore biosensor chip
are roughly similar, with the Argos value actually perhaps a
bit smaller; van de Poll et al. (1997), on the other hand,
found that an engineered Argos-like EGF mutant binds to
cell surface EGFR with lower affinity. Thus, it may well be
the case that the disparity in Spitz-vs-Argos spatial local-
ization of DER binding in Drosophila embryos arises from
currently unexamined differences among one or more of the
alternative properties such as diffusivity or trafficking. In
mammalian tissue organization, where AR, TGF, and EGF
effects show distinctions (Snedeker et al., 1991; Herrington
et al., 1997; Luettke et al., 1999), EGFR binding and
trafficking property differences among these autocrine li-
gands are known (Shoyab et al., 1989; Derynck, 1992;
French et al. 1995).
Our experimental assays are able to measure proximal
capture of ligand by producing cells. Both the ELISA and
microphysiometer setups involve cell monolayers, at
slightly subconfluent densities, on horizontal two-
dimensional surfaces. The volumes of bulk media above
these surface are sufficiently vast that once ligand escapes
cell receptor capture by significant diffusion into the verti-
cal, third dimension its probability of returning for later
capture is extremely small within the experimental assay
time periods (Forsten and Lauffenburger, 1994; Shvartsman
et al., 2001). And, because the probability of diffusion into
the vertical third dimension is similar to that of diffusion
across the horizontal two-dimensional surface, it is highly
likely that the ligand will escape into the bulk media before
traversing more than a very small number cells adjacent to
the producing cell (Forsten and Lauffenburger, 1994; Sh-
vartsman et al., 2001). Thus, although we cannot be certain
that our assays determine whether any particular ligand
molecule is captured by the very cell that produced it, we
believe that they determine, within reasonable accuracy,
the fraction of ligand molecules which captured by either
the producing cell itself or a proximal neighbor. This
assumption is validated by our previous experimental work
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demonstrating that anti-ligand “decoy” antibodies are
much less effective in interrupting autocrine signaling
loops than are anti-receptor “blocking” antibodies (Lauffen-
burger et al., 1998).
Our current assays do not, however, measure the actual
distance traversed by a ligand between production and
capture (although theoretical relationships between the
escape fraction and travel distance can be derived; Shvarts-
man et al., 2001). This would most precisely require a
method for following a particular ligand trajectory. Surro-
gate information could be obtained, at least in an averaged
sense, by observing the formation of gradients in ligand and
bound cell receptors in a three-dimensional matrix (in order
to minimize escape into a non binding third dimension
from a two-dimensional cell monolayer). This is the type of
experiment which has been employed in study of morpho-
gen behavior in developmental biology (e.g., see Jessell and
Melton, 1992; Teleman et al., 2001; Vincent and Briscoe,
2001). With relatively few exceptions, these kinds of studies
have focused on paracrine ligands and how they travel from
FIG. 5. Autocrine ligand concentration is a function of total ligand secretion rate and is not dependent on ligand/receptor binding affinity.
Using microphysiometer EGFL47M autocrine cell data, the effective autocrine ligand concentration, [L]auto, was determined as a function of
total ligand secretion rate, VLT (DeWitt et al., 2001). The total ligand secretion rate was measured in parallel by the bulk medium
conditioning assay. Red circles represent EGFL47M, while black circles represent WT EGF. The best-fit slope for the combined data, 0.0037
 0.0004, is statistically equivalent to the individual best-fit slopes for each data set separately (wild-type: 0.0036  0.0001; mutant:
0.0045  0.0010).
FIG. 6. For values of the ligand-to-receptor production ratio, VLT/VR, 1, EGFL47M autocrine ligand is locally captured less efficiently than
WT EGF. Computational model predictions for the fraction of autocrine ligand captured locally, fLC are shown for EGFL47M by the red dashed
curve (small dashes correspond to 50% intracellular complex signaling; large dashes correspond to 60% intracellular complex signaling),
and are experimentally confirmed by the data for EGFL47M (red circles). Results for WT EGF from Fig. 2 are provided for comparison [black
circles, data; black dashed curve corresponds to 60% intracellular complex signaling (see text)].
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producing cells to receiving cells; interpretation of the
experimentally observed ligand distributions is not simple
(Lander et al., 2002). The situation we study here, that of
potential autocrine operation in which the ligand-produc-
ing cells traversed express receptors for the ligand, is more
complicated yet. At the same time, autocrine signaling
loops inherently possess exceptional opportunity for regu-
lation of tissue organization (Freeman, 2000), so that our
first steps here toward improved quantitative understand-
ing may prove helpful as the number of such systems
identified in developmental applications continues to grow.
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